Related Experiment Videos
Severe malabsorption in autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy syndrome successfully treated
1Department of Paediatrics, Chaim Sheba Medical Centre, Tel-Hashomer, Israel.
Archives of Disease in Childhood
|June 1, 1997
Summary
Autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy syndrome can cause severe malabsorption. Immunosuppression with methylprednisolone and methotrexate effectively managed these debilitating symptoms in a young patient.
Area of Science:
- Endocrinology
- Immunology
- Gastroenterology
Background:
- Autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED) syndrome is a rare autoimmune disorder.
- APECED syndrome can manifest with diverse and severe gastrointestinal complications.
Observation:
- A 15-year-old male presented with recurrent severe intractable diarrhea, steatorrhea, and hypocalcemia.
- These symptoms indicated a significant malabsorption syndrome.
Findings:
- The patient's malabsorption syndrome was refractory to standard treatments.
- High-dose intravenous methylprednisolone followed by oral methotrexate maintenance therapy proved effective in controlling the symptoms.
Implications:
- This case highlights the potential efficacy of immunosuppressive therapy in managing severe gastrointestinal manifestations of APECED syndrome.
- Aggressive immunosuppression may be a viable therapeutic option for refractory malabsorption in APECED patients.
- Further research into the role of immunosuppression for APECED-related gastrointestinal dysfunction is warranted.